Follow
Vusal Babashov
Vusal Babashov
Data Scientist
Verified email at uottawa.ca - Homepage
Title
Cited by
Cited by
Year
Economic burden of nausea and vomiting of pregnancy in the USA.
C Piwko, G Koren, V Babashov, C Vicente, TR Einarson
Journal of Population Therapeutics and Clinical Pharmacology= Journal de la …, 2013
1102013
Reducing patient waiting times for radiation therapy and improving the treatment planning process: a discrete-event simulation model (radiation treatment planning)
V Babashov, I Aivas, MA Begen, JQ Cao, G Rodrigues, D D’souza, ...
Clinical Oncology 29 (6), 385-391, 2017
632017
Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) for treatment of symptomatic uterine fibroids: an economic analysis
V Babashov, S Palimaka, G Blackhouse, D O'Reilly
Ontario Health Technology Assessment Series 15 (5), 1, 2015
252015
Economic evaluation of brentuximab vedotin for persistent Hodgkin lymphoma
V Babashov, MA Begen, J Mangel, GS Zaric
Current Oncology 24 (1), 6-14, 2017
182017
Framework for drug formulary decision using multiple-criteria decision analysis
V Babashov, S Ben Amor, G Reinhardt
Medical Decision Making 40 (4), 438-447, 2020
42020
Setting wait time targets in a multi‐priority patient setting
V Babashov, A Sauré, O Ozturk, J Patrick
Production and Operations Management, 2023
12023
Cost-utility analysis of enzalutamide for patients with previously treated metastatic castration-resistant prostate cancer (MCRPC)
C Vicente, V Babashov, F Husein, F Saad, S Naidoo, S Holmstrom
Value in Health 17 (3), A89-A90, 2014
12014
Three Practical Problems in Healthcare Analytics
V Babashov
Université d'Ottawa/University of Ottawa, 2021
2021
Preliminary Economic Evaluation of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: An" Early Look" Model Based on Phase II Results
V Babashov
The University of Western Ontario (Canada), 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–9